Close Menu

NEW YORK (GenomeWeb) - WaferGen Biosystems reported after the close of the market Wednesday that its third quarter revenues rose 54 percent driven by increased SmartChip capital equipment sales.

For the three months ended Sept. 30, WaferGen reported total revenues of $2 million compared to $1.3 million in Q3 2014, in line with analysts' consensus estimate.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.